{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:41:01Z","timestamp":1759333261417},"reference-count":27,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2011,9,1]]},"DOI":"10.1185\/03007995.2011.597663","type":"journal-article","created":{"date-parts":[[2011,7,14]],"date-time":"2011-07-14T09:15:30Z","timestamp":1310634930000},"page":"1693-1703","source":"Crossref","is-referenced-by-count":21,"title":["Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain"],"prefix":"10.1185","volume":"27","clinical-trial-number":[{"clinical-trial-number":"nct00853970","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00704418","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Steven M.","family":"Silverstein","sequence":"first","affiliation":[{"name":"Silverstein Eye Centers,\rKansas City, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa G.","family":"Cable","sequence":"additional","affiliation":[{"name":"Discover Vision Centers,\rIndependence, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Sadri","sequence":"additional","affiliation":[{"name":"Atlantis Eye Care,\rNewport Beach, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Peace","sequence":"additional","affiliation":[{"name":"Diabetic Eye Medical Clinic,\rInglewood, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Fong","sequence":"additional","affiliation":[{"name":"Raymond Fong Eye Care,\rNew York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon P.","family":"Chandler","sequence":"additional","affiliation":[{"name":"ISTA Pharmaceuticals, Inc.,\rIrvine, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Gow","sequence":"additional","affiliation":[{"name":"ISTA Pharmaceuticals, Inc.,\rIrvine, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon M.","family":"Klier","sequence":"additional","affiliation":[{"name":"ISTA Pharmaceuticals, Inc.,\rIrvine, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy R.","family":"McNamara","sequence":"additional","affiliation":[{"name":"ISTA Pharmaceuticals, Inc.,\rIrvine, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Bromfenac Ophthalmic Solution Once Daily (Bromday) Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,7,14]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.4.487"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.9.1308"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767090-00004"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S4806"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-15886"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2009.07.005"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1097\/00004397-198302310-00014"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1995.01100060051031"},{"key":"CIT0009","unstructured":"ISTA Pharmaceuticals, Inc. Xibrom (bromfenac ophthalmic solution) 0.09% Package Insert, 2010"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1963.00960050484010"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2000.03288.x"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1097\/01.iio.0000212134.83513.11"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.12.029"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2007.0040"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1021\/jm00377a001"},{"key":"CIT0016","volume-title":"Lipid-Derived Autacoids: Eicosanoids and Platelet-Activating Factor","author":"Smyth EMBA","year":"2006","edition":"11"},{"key":"CIT0017","unstructured":"Kida T, Ogawa T, McNamara TR, et al. Evaluations of the human COX-2 inhibition for amfenac, bromfenac, diclofenac, and ketorolac. 33rd Symposium on Cataract, IOL, and Refractive Surgery of the American Society of Cataract and Refractive Surgery, April 27\u2013May 1, 2007, San Diego, CA, USA"},{"key":"CIT0018","unstructured":"Co SP. Bronuck Ophthalmic Solution 0.1% Package Insert. Osaka, Japan, 2009"},{"key":"CIT0019","unstructured":"ISTA Pharmaceuticals Inc. Data on file"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.12.035"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi.121.799"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2007.0082"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.06.012"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2004.00782.x"},{"key":"CIT0025","unstructured":"Alcon Laboratories. Nevanac (nepafenac ophthalmic suspension) 0.1% Package Insert. Fort Worth, TX, USA, 2008"},{"key":"CIT0026","unstructured":"Allergan, Inc. Acuvail (ketorolac tromethamine ophthalmic solution) 0.45% Package insert, Irvine, CA, USA, 2009"},{"key":"CIT0027","unstructured":"ISTA Pharmaceuticals, Inc. Bromday (bromfenac ophthalmic solution) 0.09% Package Insert. Irvine, CA, USA, 2010"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/03007995.2011.597663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T20:05:44Z","timestamp":1599422744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/03007995.2011.597663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,14]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9,1]]}},"alternative-id":["10.1185\/03007995.2011.597663"],"URL":"https:\/\/doi.org\/10.1185\/03007995.2011.597663","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"type":"print","value":"0300-7995"},{"type":"electronic","value":"1473-4877"}],"subject":[],"published":{"date-parts":[[2011,7,14]]}}}